Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in NERV — Minerva Neurosciences, Inc.

CIK 1692234 Seattle, WA
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$15,107
+$11,970 QoQ
Shares Held
2,722
+131.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 58 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. NERV ranks #270 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in NERV

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,107 2,722
2024-09-30 $3,137 1,175
2024-06-30 $3,748 1,175
2024-03-31 $3,031 1,175
2023-12-31 $7,226 1,175
2023-09-30 $8,107 1,175
2023-06-30 $10,739 1,175
2023-03-31 $1,880 1,175
2022-12-31 $1,868 1,175
2022-09-30 $10,845 1,175
2022-06-30 $3,889 1,175
2022-03-31 $7,802 9,400
2021-12-31 $7,529 9,400
2021-09-30 $161,040 92,552
2021-06-30 $219,675 94,688
2021-03-31 $299,146 102,448
2020-12-31 $500,809 214,022
2020-09-30 $750,264 235,933
2020-06-30 $734,207 203,382
2020-03-31 $929,126 154,340